GLENN T ORSAK
Allopathic & Osteopathic Physicians|Family Medicine FRIENDSWOOD, TX NPI 1174528822
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX ABBVIE INC. All categories
General Payments — all program years on this page
$10,805.23
- Category: General Payments
- Program years: PY2018–2024
- Record count: 532
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,380.61 across 69 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,380.61 | 69 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $239.59 | 21 |
| PFIZER INC. | $138.99 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $131.56 | 3 |
| Novo Nordisk AS | $116.92 | 6 |
| Amgen Inc. | $105.24 | 3 |
| DEXCOM, INC. | $92.81 | 4 |
| Acerta Pharma LLC | $90.22 | 4 |
| Lilly USA, LLC | $81.07 | 4 |
| Esperion Therapeutics, Inc. | $69.52 | 3 |
| JAZZ PHARMACEUTICALS INC. | $49.33 | 2 |
| Exact Sciences Corporation | $44.65 | 3 |
| ABIOMED | $31.75 | 1 |
| GlaxoSmithKline, LLC. | $31.59 | 2 |
| Janssen Pharmaceuticals, Inc | $29.88 | 1 |
| Antares Pharma, Inc. | $29.25 | 2 |
| Sumitomo Pharma America, Inc. | $25.70 | 1 |
| Abbott Laboratories | $21.58 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.26 | 1 |
| Currax Pharmaceuticals LLC | $14.97 | 1 |
| Hikma Pharmaceuticals USA | $14.73 | 1 |
By program year
Records — PY2024 (69)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.